GUERRA, TOMMASO
 Distribuzione geografica
Continente #
NA - Nord America 183
EU - Europa 84
AS - Asia 14
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 284
Nazione #
US - Stati Uniti d'America 183
IT - Italia 29
SE - Svezia 28
CN - Cina 11
DE - Germania 7
CZ - Repubblica Ceca 6
FR - Francia 3
GB - Regno Unito 3
PT - Portogallo 3
A1 - Anonimo 2
BE - Belgio 2
IN - India 2
AR - Argentina 1
FI - Finlandia 1
GR - Grecia 1
SG - Singapore 1
UA - Ucraina 1
Totale 284
Città #
Chandler 60
Nyköping 25
Fairfield 13
Ashburn 10
New York 8
Houston 6
Lawrence 6
Brno 5
Roxbury 5
Seattle 5
Bari 4
Woodbridge 4
Bisceglie 3
Cambridge 3
Des Moines 3
Munich 3
Wilmington 3
Boardman 2
Brussels 2
Guangzhou 2
Paris 2
Terlan 2
Ann Arbor 1
Beijing 1
Brooklyn 1
General Pacheco 1
Grafing 1
Helsinki 1
Imbersago 1
Indianapolis 1
Inglewood 1
Jiaxing 1
Jinhua 1
Kilburn 1
Marseille 1
Milan 1
Naples 1
New Delhi 1
Olomouc 1
Princeton 1
Pune 1
Redwood City 1
Singapore 1
Triggiano 1
Wuhan 1
Totale 199
Nome #
Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 years 53
Dengue fever in a multiple sclerosis patient taking Ocrelizumab 48
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide 42
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis 40
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 35
Predictors of unemployment status in people with relapsing multiple sclerosis: a single center experience 27
null 21
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients 13
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register 9
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register 8
Multiple Sclerosis Progression and Relapse Activity in Children 2
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry 2
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 1
Totale 301
Categoria #
all - tutte 2.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 1 1 0 1 0 0 1
2020/202132 0 0 0 7 4 1 0 3 4 4 7 2
2021/202258 4 10 3 0 3 4 0 6 1 5 8 14
2022/2023116 17 18 6 16 10 11 3 11 18 1 4 1
2023/202481 6 11 2 5 13 14 4 2 1 2 4 17
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 301